Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2025-02-27 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
港股公告：翌日披露报表
Transaction in Own Shares Classification · 95% confidence The document is a detailed disclosure report about changes in issued shares and treasury shares, including share issuance under equity plans and share repurchases, with references to Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It includes specific share counts, dates, prices, and confirmations of compliance with listing rules. The document is structured as a regulatory disclosure form (FF305) for share capital changes and share repurchases, not a financial report or earnings release. It is not an announcement of a report but the actual disclosure itself. This matches the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length is 4050 characters, sufficient for a detailed disclosure but not a full annual or interim report. Therefore, the correct classification is POS with high confidence.
2025-02-27 Chinese
百济神州有限公司关于董事会审计委员会主席变更的公告
Board/Management Information Classification · 100% confidence The document is a short announcement (529 characters) regarding a change in the company's board committee leadership, specifically the appointment of a new chairman of the audit committee and the continuation of a member. It does not contain financial data, audit results, or detailed reports. It is clearly an announcement about a board/management change. Therefore, it fits the category of Board/Management Information (MANG).
2025-02-27 Chinese
百济神州有限公司自愿披露关于2025年度经营业绩预测的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement regarding the company's forecasted operating performance for the year 2025. It provides estimated revenue, profit margins, expenses, and cash flow expectations, but it explicitly states that these are preliminary forecasts not audited or reviewed by auditors and that actual results will be disclosed in the future audited annual report. The document is relatively short (1640 characters) and serves as a forward-looking performance prediction rather than a full financial report. It does not contain actual financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS) because it is an announcement of forecasted performance and risk factors, not a formal financial report like an Annual Report (10-K) or Interim Report (IR).
2025-02-27 Chinese
百济神州有限公司2024年度业绩快报公告
Annual Report Classification · 95% confidence The document is titled as a "2024年度业绩快报公告" which translates to "2024 Annual Performance Express Announcement". It contains detailed preliminary financial data for the year 2024, including revenue, profit, and other financial metrics. The data is unaudited and the company states that the final audited data will be in the 2024 Annual Report. The document also discusses business performance, product sales, clinical trials, and risk factors. The length is over 7,000 characters and it contains substantive financial data and analysis for the full fiscal year 2024. This matches the characteristics of an Annual Report (10-K) type document, specifically an earnings release or preliminary annual results announcement. However, since it is a detailed preliminary financial report for the full year with financial data and business analysis, it fits best as an Annual Report (10-K) type filing rather than a short earnings release or a report publication announcement. Therefore, the classification is 10-K with high confidence. FY 2024
2025-02-27 Chinese
美股公告：年度报告10-K表格
Annual Report Classification · 100% confidence The document is a detailed and comprehensive filing titled "Form 10-K" for the fiscal year ending December 31, 2024, submitted to the U.S. Securities and Exchange Commission (SEC). It includes extensive sections typical of an annual report such as business overview, risk factors, legal proceedings, management's discussion and analysis, financial statements, and corporate governance. The presence of detailed financial data, management discussion, and regulatory compliance information confirms it is the official yearly report covering the company's full financial performance and activities. The document explicitly identifies itself as a "10-K" and contains the full content expected in such a filing, not merely an announcement or summary. Therefore, the correct classification is Annual Report (10-K). FY 2024
2025-02-27 Chinese
百济神州有限公司关于持股5%以上股东权益变动的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about changes in shareholding percentages of shareholders holding more than 5% of the company's shares. It details the issuance of new shares and the resulting dilution of shareholding percentages without any change in the actual number of shares held by major shareholders. The document explicitly states it is a "提示性公告" (a prompt or indicative announcement) regarding changes in shareholding above 5%. There is no financial statement, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds. The document length is short (2601 characters), and it is not an announcement of a report publication but a direct notification of shareholding changes.
2025-02-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.